Dr. Paul Marik discusses the recent rise in “turbo cancers”—aggressive, rapidly advancing cancers—and attributes the surge to the immune system disruptions caused by COVID-19 and its treatments. He emphasizes the need for targeted strategies to address these evolving cancer trends, which demand further research and clinical response.
For more details, you can read the full article here.